iTeos Therapeutics, Inc.: cashflow_investing
| Value | {"amount": -11591000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-06-30 |
| Status | current |
| Entity | iTeos Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:13:05.345676+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/52682eba-18fb-46d1-a557-2234d111104f
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-23-039341Retrieved: 2026-08-19T18:13:05.345676+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001808865/cashflow-investing/2023-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/52682eba-18fb-46d1-a557-2234d111104f
History
- no predecessors — first report